These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 11991674)
1. Different activities of type I interferons on hepatitis B virus core promoter regulated transcription. Schulte-Frohlinde E; Seidler B; Burkard I; Freilinger T; Lersch C; Erfle V; Foster GR; Classen M Cytokine; 2002 Feb; 17(4):214-20. PubMed ID: 11991674 [TBL] [Abstract][Full Text] [Related]
2. Cytokine inhibition of the hepatitis B virus core promoter. Romero R; Lavine JE Hepatology; 1996 Jan; 23(1):17-23. PubMed ID: 8550037 [TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-specific gene expression from integrated lentiviral vectors. Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070 [TBL] [Abstract][Full Text] [Related]
4. Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon. Xiong W; Wang X; Liu XY; Xiang L; Zheng LJ; Liu JX; Yuan ZH Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1053-60. PubMed ID: 14673494 [TBL] [Abstract][Full Text] [Related]
5. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter. Tacke F; Liedtke C; Bocklage S; Manns MP; Trautwein C Gut; 2005 Sep; 54(9):1309-17. PubMed ID: 15871998 [TBL] [Abstract][Full Text] [Related]
6. In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation. Wang Y; Wei L; Jiang D; Cong X; Fei R; Chen H; Xiao J; Wang Y Antiviral Res; 2007 Aug; 75(2):139-45. PubMed ID: 17397939 [TBL] [Abstract][Full Text] [Related]
7. Characterization of nonconventional hepatitis B viruses lacking the core promoter. Chang SF; Chang SH; Li BC; Will H; Netter HJ Virology; 2004 Dec; 330(2):437-46. PubMed ID: 15567437 [TBL] [Abstract][Full Text] [Related]
8. Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice. Dumortier J; Schönig K; Oberwinkler H; Löw R; Giese T; Bujard H; Schirmacher P; Protzer U Gene Ther; 2005 Apr; 12(8):668-77. PubMed ID: 15647761 [TBL] [Abstract][Full Text] [Related]
9. The role of helioxanthin in inhibiting human hepatitis B viral replication and gene expression by interfering with the host transcriptional machinery of viral promoters. Tseng YP; Kuo YH; Hu CP; Jeng KS; Janmanchi D; Lin CH; Chou CK; Yeh SF Antiviral Res; 2008 Mar; 77(3):206-14. PubMed ID: 18249449 [TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma regulation of the human mimecan promoter. Tasheva ES; Conrad GW Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654 [TBL] [Abstract][Full Text] [Related]
11. Bioluminescence imaging of hepatitis B virus enhancer and promoter activities in mice. Du J; Zhou Y; Fu QX; Gong WL; Zhao F; Peng JC; Zhan LS FEBS Lett; 2008 Oct; 582(23-24):3552-6. PubMed ID: 18822287 [TBL] [Abstract][Full Text] [Related]
12. A recombinant CHSE-214 cell line expressing an Mx1 promoter-reporter system responds to both interferon type I and type II from salmonids and represents a versatile tool to study the IFN-system in teleost fish. Jørgensen JB; Johansen A; Hegseth MN; Zou J; Robertsen B; Collet B; Secombes CJ Fish Shellfish Immunol; 2007 Dec; 23(6):1294-303. PubMed ID: 17804253 [TBL] [Abstract][Full Text] [Related]
13. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. Zheng Y; Li J; Ou JH J Virol; 2004 Jul; 78(13):6908-14. PubMed ID: 15194767 [TBL] [Abstract][Full Text] [Related]
14. Interferon-mediated enhancement of in vitro replication of porcine circovirus type 2 is influenced by an interferon-stimulated response element in the PCV2 genome. Ramamoorthy S; Huang FF; Huang YW; Meng XJ Virus Res; 2009 Nov; 145(2):236-43. PubMed ID: 19631245 [TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses. Buckwold VE; Wei J; Huang Z; Huang C; Nalca A; Wells J; Russell J; Collins B; Ptak R; Lang W; Scribner C; Blanchett D; Alessi T; Langecker P Antiviral Res; 2007 Feb; 73(2):118-25. PubMed ID: 16987555 [TBL] [Abstract][Full Text] [Related]
16. Induction of SV40 early transcription by type I interferon. Tzen CY; Scott RE Exp Cell Res; 1993 Apr; 205(2):246-50. PubMed ID: 8387014 [TBL] [Abstract][Full Text] [Related]
17. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission. Zampino R; Marrone A; Karayiannis P; Cirillo G; del Giudice EM; Rania G; Utili R; Ruggiero G Am J Gastroenterol; 2002 Sep; 97(9):2426-31. PubMed ID: 12358268 [TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy. Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007 [TBL] [Abstract][Full Text] [Related]
19. Interferon-omega suppresses hepatitis B surface antigen production in human hepatoma cell line. Hajnická V; Fuchsberger N; Liptáková H; Stancek D; Kontsek P Acta Virol; 1996 Sep; 40(4):221-2. PubMed ID: 9014013 [TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of IRF3 and IRF7 in rainbow trout, Oncorhynchus mykiss: functional analysis and transcriptional modulation. Holland JW; Bird S; Williamson B; Woudstra C; Mustafa A; Wang T; Zou J; Blaney SC; Collet B; Secombes CJ Mol Immunol; 2008 Dec; 46(2):269-85. PubMed ID: 18805586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]